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ABSTRACT 
Low back pain (LBP) is a common musculoskeletal problem that is often chronic or recurrent. Myofascial 
trigger points (MTrPs) cause low back pain and are prevalent in patients with LBP. The aim of this study was 
to assess the effectiveness of multimodal treatment of MTrPs in patients with chronic low back pain. A single-
assessor, blinded, randomized, controlled trial was conducted at Mannam Ayurveda Medical College, 
Pandalam. The intervention group received comprehensive treatment on alternate days consisting of trigger 
point releasing by manual compression of the MTrPs, stretching of the muscles and Dhanyamla dhara. 
Patients were instructed to perform muscle-stretching and relaxation exercises and maintain good posture. 
The control group was received only Dhanyamla dhara. The Oswestry Low Back Pain Disability questionnaire 
score (OLBPD) (primary outcome), Visual Analogue Scale for Pain (VAS-P), and the number of muscles with 
MTrPs were assessed at base line, 3 and 6 weeks in the intervention group and compared with those of a 
control group. As compared to the control group, the intervention group showed significant improvement 
(P < 0.05) on the OLBPD after 6 weeks. The results of this study show that 6-week comprehensive treatment 
of MTrPs in lower back muscles such as Piriformis, Quadratus lumborum, and iliopsoas muscles reduces the 
number of muscles with active MTrPs and is effective in reducing symptoms and improving Sciatica. IVDP can 
be prevented by early detection and deactivation of Myofascial trigger points. Combination therapy of trigger 
point releasing with Ayurvedic therapies shows highly beneficial in LBP. 
KEYWORDS: Gridhrasi, Myofascial trigger points, Pressure release, Piriformis syndrome, Dhanyamla dhara, 
muscle stretching, pain scale. 
INTRODUCTION
 Trigger points are defined as discrete, focal, 
hyperirritable spots located in taught band of skeletal 
muscle, which are painful on compression and can produce 
local and referred pain, which can perplex medical 
professionals who are not familiar with trigger points. The 
aim of this study was to assess the effectiveness of 
multimodal treatment of Myofascial Trigger points 
(MTrPs) in patients with chronic low back pain. However, 
several case studies have suggested that the treatment of 
MTrPs in patients with low back pain may be beneficial; 
although well-designed controlled studies are still lacking. 
Modern medicine tends to overlook the muscles as a 
source of pain, preferring to concentrate on the nerve and 
disc problems. [1] 
 The misdiagnosis of pain is the most important 
issue taken by Travell and Simons. Referred pain from 
trigger points mimics the symptoms of a very long list of 
common maladies, but physicians, in weighing all the 
possible causes for a given condition, rarely consider a 
myofascial source. The study of trigger points has not 
historically been part of medical education. Travell & 
Simons hold that most of the common everyday pain is 
caused by myofacial trigger points and that ignorance of 
the basic concept could inevitably lead to false diagnosis 
and ultimate failure to deal effectively with pain. 
 The common cause of muscle pain is myofascial 
pain caused by myofascial trigger points. A trigger point is 
caused by certain malfunction of the junction between the 
nerve fibers and the muscle fibers. This malfunction causes 
the group of muscle fibers to stay contracted, even when 
the muscle is relaxed. These groups of contracted muscle 
fibers resemble a knot in a rope, and affect the muscle in 
the following ways, such as Increased Muscle tension: The 
contracted group of muscle fibers prevents the muscle 
from completely relaxing, causing the muscle to be tense 
and stiff. Muscle weakness The presence of the contracted 
fibers prevents the muscle from contracting fully and 
smoothly, and thus impairing the strength of the muscle. 
Muscle Fatigue: The constantly contracted group of muscle 
fibers utilizes an incredible amount of energy, exhausting 
the supply of oxygen for the rest of the muscle fibers. This 
causes the muscle to feel lethargic and fatigued. Muscle 
spasm: A trigger point is actually like a tiny spasm in a 
muscle. Over a period of time, as the muscle become 
exhausted, more and more groups of muscle fibers become 
involved, leading to a fully fledged muscle contraction. [2-6] 
 Once a trigger point is activated, waste products 
will begin to accumulate. These waste products are nerve 
irritants, and perpetuate pain. Due to the accumulation of 
waste product, blood supply to the area is interrupted; 
resulting in a contracture (tight band) of muscle fibers and 
ischemia, and results in pain are felt by the patient. In 
addition to affecting the proper functioning of muscles, 
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trigger points affects the nervous system by producing 
referred pain and other symptoms.  
Other symptoms related to trigger points 
 Tingling or Numbness in various regions of the 
body, Visual disturbance. Vertigo and Balance problems, 
Excessive tearing of eye or redness, Soreness of throat, Dry 
cough, Sinus head ache and discharge, Abdominal bloating 
and heart burn, Pelvic cramps etc. 
Sciatica: piriformis syndrome is one of the many causes of 
sciatica. Piriformis muscle spasms compress the sciatic 
nerve, results in the radiating leg pain. The pain is worse 
with prolonged sitting or standing. The pain is initially 
minimal when walking, but increases after a certain 
distance, but increases after a certain distance. 
 Pain, weakness, numbness and other discomforts 
along the path of the sciatic nerve-often accompanies low 
back pain, which afflicts every adult from time to time, 
costing billions of dollars in healthcare and more lost days 
work than anything of. In Ayurveda, this condition is 
termed as Gridhrasi and most of the doctors believed this 
as a result of herniated disc.[7] But in our opinion, the IVDP 
is not the cause in all cases. Gridhrasi is a neuromuscular 
disorder that occurs when the sciatic nerve is compressed 
or otherwise irritated by the piriformis muscle causing 
pain, tingling and numbness in the buttock and along the 
path of the sciatic nerve.  
 The tendons (Kandaras) originating from 
calcanium goes to the phalanges, get vitiated by Vatha due 
to over use or mal alignment, exerts over strain on the 
muscles and tendon, the foot become unstable on walking 
and as a result the external rotators (piriformis muscle) 
gets over strained. Because of the overstrain exerted on 
the piriformis muscle (muscles of buttocks), myofascial 
trigger points will develop on these muscles- (Charaka 
described this pain distribution in such a way that “spik 
poorve kadee prishtooru janu jangha padam kramat”)[8] 
means – the pain starts at the buttocks and then spreads to 
lumbar and descending down the thigh and in to the leg. 
The muscular strain causes inflammation, shortening of 
the muscle and increase the bulk (due to the accumulation 
of waste products) that causes compression on the sciatic 
nerve. Generally this condition is known as piriformis[9] 
syndrome refers to sciatica symptoms, not originating 
from disc herniation. There are various other activities 
such as prolonged sitting, poor posture for extended time, 
long distance driving, trauma, twisting of pelvis etc. may 
cause over load to the piriformis muscle and results in 
sciatica symptoms. An unresolved piriformis syndrome 
can contribute trigger points to other muscles such as 
Quadratus lumborum, Iliopsoas, gluteus muscles etc. 
results in severe type of low back pain. 
 There can be as many as ten muscle groups 
involved in a low back disorder. A simple case of low back 
pain may involve only two or three muscle group, but if left 
untreated, up to ten additional muscle groups may be 
involved. The trigger points in these additional muscle can 
produce sciatica like pain or numbness that down the leg. 
The following muscle groups are primarily involved in 
most of the low back pain disorders. 
 
 The Piriformis muscle 
 The Quadratus lumborum muscle 
 The Gluteus medius & minus 
 The Iliopsoas muscles 
Piriformis Syndrome: It is a neuromuscular disorder that 
occurs when the sciatic nerve is compressed or irritated by 
piriformis muscle causing pain, tingling and numbness in 
the buttocks and along the path of the sciatic nerve 
descending down the thigh and in to the leg. Diagnosis is 
often difficult due to few standardized diagnostic tests, but 
one of the most important criteria is to exclude sciatica 
resulting from compression/irritation of spinal nerve 
roots, as by a herniated disc. The syndrome may be due to 
certain anatomical variations in the muscle- nerve 
relationship, or from overuse or strain. When the 
piriformis muscle shortens or spasms due to trauma or 
over use, trigger points develops in it, and it can compress 
the sciatic nerve beneath the muscle. This particular 
condition known as piriformis syndrome refers to sciatica 
symptoms not originating from spinal roots and /or spinal 
disc herniation, but involving the overlying piriformis 
muscle. More than 16% of all adult work disability 
evaluations and examinations are performed to rate the 
patient's partial or total disability associated with chronic 
low back pain. It is estimated that at least 6% of patients 
who are diagnosed as having low back pain actually have 
piriformis syndrome.[9] There are two trigger points in the 
piriformis muscle, which is deep inside the buttock. 
Generally, the medial trigger point refers pain to the 
sacroiliac joint area, while the lateral trigger point has 
referral pain mainly in the posterior hip area. However, 
both trigger points are known to cause pain to affect all 
three regions (posterior hip, sacroiliac joint, and the 
general area of the buttock). 
 
Delay in diagnosing piriformis syndrome may lead to 
pathologic conditions of the sciatic nerve, chronic somatic 
dysfunction, and compensatory changes resulting in pain, 
paresthesia, hyperesthesia, and muscle weakness. 
Neuromuscular therapy: (Trigger point therapy) is a 
very specific form of body work, the goal of which is to re- 
establishes a balance between the nervous system and 
muscular systems thereby balancing the body. Therapeutic 
treatments for addressing soft tissue injuries involve 
massage therapy, manual therapy; trigger point therapy, 
or Active Release Technique. These treatments increase 
blood flow, decrease muscle spasms, enhance flexibility, 
speed healing, and promote proper tissue repair. 
  A Neuromuscular therapy session is based on a 
thorough posture and movement analysis to spot the 
imbalance and break the dysfunctional cycle. [16] Clinical 
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trigger point therapy is a systematic, comprehensive 
approach to relieving physical pain. The system is based 
on the research of Drs.Janet Travell M.D. and David Simons 
M.D. and was developed by Dr.Laura Perry in 2001. 
Trigger point therapy can reduce pain, increase movement, 
and allows the muscle to lengthen and become stronger 
again. To treat trigger points, heavy pressure must be 
applied to the trigger point. Light pressure is not effective 
for treating trigger points, and in fact may increase spasms 
as the muscle tries to protect itself leading to increased 
and more constant pain. In contrast, moderate to heavy 
pressure applied to a trigger point causes the pain to 
initially increase, but then as the muscle relaxes, the pain 
will fade. Pressure should be applied slowly and released 
slowly for best result. The pressure should be maintained 
until there is a change in pain. If there is no decrease in 
pain after one minute, stop the pressure- this is probably 
not a trigger point. After applying pressure to trigger 
points, the relaxed muscles should be stretched. If the 
muscles are not returned to normal length, there is a 
greater likelihood the trigger point will reoccur. Stretching 
is safer and less painful after the trigger points have been 
released. When pressure is applied to the trigger point, the 
chemical/ pressure cycle is interrupted, which helps to 
stop the contraction and the pain in the muscle. 
Additionally, the muscle is heated and kneaded during 
treatment, which helps to increase circulation and to 
remove the metabolic waste products. Dhanyamla dhara is 
a sudation procedure described in Ayurveda especially in 
Kerala Panchakarma therapies. Dhanyamlam is a specially 
prepared liquid medicament. As per this procedure, 
moderately heated Dhanyamla will be poured all over the 
body except head after covering the body with a cotton 
cloth. The duration of treatment will be 40 to 50 minutes 
to generate sweating. This will dilate the blood vessels and 
enhance blood circulation, by which eliminate the 
metabolic waste products through the sweat. According to 
Ayurvedic principles, the sudation process will liquefy the 
waste products from all over the body and carry it to the 
Koshta (intestine). From there, it can be eliminated by 
Virechana or Vasthi. While stretching the muscle, the 
muscle fibers become lengthened which decreases the 
pressure component of the pain cycle. It is important to 
understand that trigger points are not the same as 
acupressure points or Marma points. For treatment to be 
effective, the specific trigger points or contracted portion 
of the muscle must be released. 
 The aim of the current study was to assess the 
effectiveness of a comprehensive treatment program of 
MTrPs in lower back and buttock muscles on symptoms 
and the functioning of the lower back in patients with 
chronic non traumatic, non specific low back pain 
compared with a control group. 
MATERIALS AND METHODS 
A single-blinded RCT was conducted, which was approved 
by the Medical Ethics Committee of the Mannam Ayurveda 
Medical College, Pandalam, and the study protocol was 
accepted and financed by Kerala State Council For Science, 
Technology And Environment, Thiruvananthapuram. 
Patients in the study sample 
 The patients were recruited by conducting 
medical camps after publicity through news papers/local 
channels; or referred by other doctors of nearby hospitals. 
A total number of 90 patients were selected on the basis of 
below inclusion and exclusion criteria. The suitable 
patients who consented for participation in the trial were 
randomly divided into two Groups of 45, namely 
Intervention Group & Control Group. Three patients from 
intervention group and One patient from control group 
were dropped out from the trial due to their personal 
inconvenience.  
The inclusion criteria 
 Patients being in the age between 18 years and 65 
years, LBP with sciatica of duration of more than 6 weeks 
and less than 6 months for the current episode, agreement 
for randomization and willingness to sign an informed 
consent form. 
The Exclusion criteria 
 Specified pregnancy, serious medical problems 
(e.g. peripheral neuropathy, multiple sclerosis, hemiplegic, 
myelopathy etc.) urinary incontinence, spine disorders 
with boney lesions (e.g. osteoporosis, fracture, unstable 
spondylolysthesis, multiple myeloma), with radiographs 
taken as clinically indicated, significant mental disorders 
(e.g. psychosis, mania, major depression), litigation, 
automobile injuries, work injuries and history of lumbar 
surgery.  
I. Subjective parameters 
1. Pain 
Please describe your current pain complaint:  
Please indicate (by shading in) where you are experiencing 
your pain (or other symptoms): 
Please indicate (by circling) which term(s) best describe your symptoms: 
Aching  Burning   Stabbing  Tender to Touch 
Sharp, well defined  Tingling   Shooting  Radiating 
Diffuse, poorly defined  Numbness   Cramping  Throbbing 
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Severity of Pain: 
 Please indicate (circle) the severity of your pain: 
(No Pain) 0.…1.…2.…3….4….5….6….7….8.…9.…10 (Severe Pain) 
Treatment Area/Body Part Pain 
1 = No pain 
2 = Tolerable discomfort 
3 = Minimal pain, when in certain positions or situations, can be ignored 
4 = Pain cannot be ignored, but can be tolerated, minimal concentration interference 
5 = Pain occasionally interferes with concentration, minimal pain compensation behaviors, performance difficulties 
with one or two tasks 
6 = Pain interferes with concentration and/or performance difficulties 25% of the time, pain compensation 
behaviors displayed 
7 = Pain interferes with concentration and performance difficulties 50% of the time, pain compensation behaviors 
displayed 
8 = Pain interferes with concentration and performance difficulties 75% of the time, pain compensation behaviors  
displayed 
9 = Pain continuously interferes with concentration and performance is limited, pain compensation behaviors 
displayed 
10 = Intolerable pain, concentration and performance interference except basic needs of eating,  toileting 
1.2 After treatment 
 Please circle the percentage of your improvement since beginning therapy: 
0 10 20 30 40 50 60 70 80 90 100 
  | | | | | | | | | | |  
            
No improvement         Complete recovery 
2. Low back Pain Disability Score 
Scoring the Modified Oswestry Low Back Pain Index 
• The first statement in each section has a value of 0, the 
second a value of 1, the third 2, the fourth 3, the fifth 4, 
and the last statement 5. If a patient marks 2 boxes, 
score the highest value box. 
• Add the scores. If the patient didn’t complete all 
sections, the final score is divided by the total possible 
score (5 for each section answered), and then 
multiplied by 100 to determine a disability percentage. 
Example: If only 9 sections were answered for a total of 
24, then 24/45 = 0.53. Multiplied by 100 = 53%. 
• All values should be rounded to the nearest whole 
number, i.e. 26.5 is 27% and 33.33 is 33%. 
• Put the actual disability percentage in the functional 
assessment score section of the EMR. 
Objective parameters 
1. Number of trigger points (tender spots) in lower 
back and buttock muscles 
Identification of Trigger points by palpation of the 
following muscles 
a. Piriformis Muscle   
b. Quadratus Lumborum Muscle  
c. Iliopsoas Muscle 
d. Gluteus Medius Muscle 
The identified trigger points were marked in the above 
picture used for the pain description. Number of trigger 
points was assessed before and after treatment. 
2. Presence of taut band 
3. Presence of nodule 
4. Local Twitch response 
5. Local or referred pain  
 
Sample size 
 The planned sample size was determined on the 
basis of an assumed mean improvement of the primary 
outcome, a Oswestry Low Back Pain Disability 
questionnaire score of 10 points (SD ± 22), which implies 
an effect size of 0.68 To test the null hypothesis at α = 0.05 
with 90% power and assuming a uniform dropout rate of 
5%, it was calculated that 45 patients in each group would 
be required. 
Randomization 
 After collection of patients' data at baseline, the 
included patients were randomly assigned to either the 
intervention group or the control group. A research 
assistant performed the randomization by generating 
random numbers using Research Randomizer software 
(http://www.randomizer.org/) These numbers were 
stored on a computer and were accessible only by the 
research assistant. No stratification or blocking strategies 
were used. 
Blinding, Outcome Assessment- Blinding of the patients 
and the treating therapists was impossible because of the 
treatment characteristics. Hence a blinded independent 
assessor from our institution with no previous contact 
with the patient performed the assessment. The 
assessments were made at intake, prior to randomization 
and at 3, and 6 weeks. The total number of back and 
buttock muscles with active and latent MTrPs was 
counted. For every patient, only one observer was active. A 
detailed medical history were taken, which include 
demographic variables and potential prognostic factors 
and a set of self administered questionnaires regarding 
outcome measurements, including the Oswestry Disability 
Index questionnaire, and the Visual Analogue Scale for 
Pain (VAS-P). Subsequently, upon completion of 14 
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treatment sessions within 3 weeks, the patient was asked 
once again to fill out all questionnaires and forms, and 
follow-up physical examinations were performed. A third 
assessment was carried out after six weeks. 
Interventions 
 The treatment started with inactivation of active, 
pain-producing MTrPs by manual compression by the 
principal investigator. The PI applied gentle, gradually 
increasing pressure on the MTrP until the finger 
encountered a definite increase in tissue resistance. At that 
point, the patient commonly would feel a certain degree of 
discomfort or pain. The pressure was maintained until the 
therapist sensed relief of tension under the palpating 
finger or the patient experienced a considerable decline in 
pain. At that point, the PI could repeat this procedure 
several times until pressure on the MTrP would provoke 
only a little discomfort without pain. This technique was 
combined with other manual techniques, such as deep 
stroking (pressure directed along the length of the taut 
band) or strumming (pressure applied perpendicularly 
across the muscle fibers). Both techniques can manually 
stretch the trigger point area and the taut band. These 
manual techniques could be preceded or followed by 
“Dhanyamladhara". The effectiveness of muscle-stretching 
exercises was enhanced by including short isometric 
contractions and relaxation (hold-relax). Patients were 
instructed to perform simple gentle static stretching and 
relaxation exercises at home several times during the day. 
All patients received ergonomic advice and instructions to 
assume and maintain good posture.  
 According to Travell, ischemic compression 
decreases the sensitivity of painful nodules in muscles. 
Simons proposed that local pressure may equalize the 
length of sarcomeres in the involved Trp and consequently 
decrease the pain. Additionally, the subsequent tissue 
relaxation created by attaining a position of TrP ease has 
been proposed as a mechanism of facilitating unopposed 
arterial filling which allows for a reduction of tone in the 
tissues involved. This reduction in local tone further 
results in the improvement of local circulation and 
decreased pain. 
 The patients in the control group were given mild 
massage and Dhanyamladhara only for a treatment session 
of 14 days within 3 weeks. All individual treatments, 
however, were consistent with the limits of the treatment 
protocol. 
Data assessment 
 Two Doctors each from Kayachikitsa and 
Salyathantra department performed the physical 
examination, of the lumbar spine and the MTrP palpation 
of the back and buttock muscles. The total number of 
muscles with active and latent MTrPs was counted. The 
observing doctors were blinded to the patient treatment 
allocations during the entire study period. The 
assessments were made at intake, prior to randomization 
and at 3, and 6 weeks. For every patient, only one observer 
was active. A detailed medical history was completed, 
which included demographic variables and potential 
prognostic factors and a set of self-administered 
questionnaires regarding outcome measurements, 
including the OLBPD questionnaire, the Visual Analogue 
Scale for Pain (VAS-P). After the data from the worksheet 
were transferred into the statistical software packages 
SPSS for windows Version 10. The analyses were based on 
an intent-to-treat methodology such that all data’s were 
analyzed regardless of patient compliance. The analyses 
were performed using one-way- variance (ANOVA) on the 
two groups, with contrasts for comparisons of individual 
groups. 
Stop rule 
 Treatments were discontinued when patients 
were completely free of symptoms or when the patient and 
physical therapist agreed that treatment would not further 
benefit the patient. Participation in the study continued 
unless patients decided to stop participation in the study. 
Patients were free to withdraw from the study at any time 
without consequences for their treatment. 
Outcome measures 
Primary outcome measure 
 The Oswestry Low Back Pain Disability 
questionnaire is an internationally widely used 
multidimensional 10-item self-report measure focusing on 
physical function, pain and emotional and social 
parameters The score ranges from 0 to 50 whereby a 
higher score indicates greater disability. The Minimal 
Clinically Important Difference (MCID) is approximately a 
10-point difference between pre- and post treatment. 
Secondary outcome measures 
 The Visual Analogue Scale for Pain (VAS-P) is a 
self-report scale consisting of a horizontal line 10 cm in 
length that is anchored by the ratings "no pain" at the left 
side (score 0) and "worst pain imaginable" at the right side 
(score 10), The VAS-P1 was used to measure pain at the 
current moment or at the base line before treatment., 
average pain after treatment of 21 days was measured as 
VAS-P2 and the most severe pain after 42 days was 
measured as VAS-P3. A 4-cm change is considered to be a 
MCID in patients with Low back pain. 
 The total number of back and buttock muscles 
with MTrPs was counted using the same methods as at 
baseline and then compared with the baseline 
measurements. While the patient was in a supine or prone 
position, depending on the muscle that was examined, 17 
muscles were palpated bilaterally for the presence of a 
taut band, spot tenderness, the presence of a nodule, local 
twitch response and local and referred pain. When the 
patient recognized the pain from compression on the 
tender spot, the MTrPs were considered to be active. When 
the pain was only local and not familiar, MTrPs were 
considered to be latent. At base, 3, and 6 weeks, 
participants were asked to complete a self-assessment 
form, which included questions regarding whether they 
had changed their self-management or had received any 
medical treatment that could have influenced. 
Statistical analysis 
 Both groups were compared for baseline 
characteristics using a t-test and a χ2 test for binominal 
variables. For the OLBPD, VAS-P and the number of 
muscles with MTrPs, the repeated measures test was used 
to assess the significance of treatment between the two 
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groups at week 3rd, and 6th week. We considered a mean 
difference of more than 10 points on the OLBPD as a MCID. 
Effect sizes measured using Cohen's d was calculated to 
examine the average impact of the intervention. According 
to the method of Cohen, d ≈ 0.2 indicates small effect and 
negligible clinical importance, d ≈ 0.5 indicates medium 
effect and moderate clinical importance and d ≈ 0.8 
indicates a large effect and crucial clinical importance. To 
compare patients who improved by more than 10 points 
with patients who improved by less than 10 points on the 
OLBPD questionnaire, we calculated the relative risk (RR) 
and the 95% confidence interval (95% CI). The 
proportions of patients who had clinically improved 
between groups were compared by calculating the RR and 
the 95% CI at 6 weeks and 12 weeks. Pearson's correlation 
coefficients were used to relate the variables of number of 
muscles with active MTrPs and the OLBPD questionnaire 
score. 
 In addition, the effect of the intervention was 
evaluated by using regression analysis. Covariates in this 
multiple linear regression model were the OLBPD 
questionnaire score at 6th week as the dependent variable, 
the group variable as the OLBPD questionnaire score at 
baseline, and the number of muscles with active MTrPs at 
intake.  
 To evaluate the success of the blinding procedure, 
both observers were asked to identify the treatment 
allocation. A goodness-of-fit χ2 test was used to determine 
whether the number of correctly and incorrectly identified 
cases fitted a probability of 50%. For all comparisons, P < 
0.05 was considered statistically significant (two-tailed). If 
the 95% CI of the difference did not include the value 0, 
the difference was statistically significant at α = 0.05.  
OBSERVATIONS AND RESULTS 
 Between September 2014 and September 2016, 
104 patients were randomly assigned to either the 
intervention group or the control group. At baseline, both 
groups were comparable with regard to all variables and 
had no statistically or clinically relevant differences, except 
for the number of muscles with latent MTrPs. 
The observations and results in signs and symptoms in 
control and the intervention groups have been made in the 
following headings.  
(1) Symptom wise observations  
(2) Oswestry low back pain disability score (OLBPD) 
(3) Visual analogue scale for pain(VASP) and 
(4) The Number of trigger points present. 
Table 1: Comparative assessment of symptomatic relief in control group 
SNO Symptoms Mean 
BT 
Mean 
AT 
Mean 
diff 
SD SE T 
value 
P 
value 
result 
1 Presence of taut band 2.295 1.5227 0.7727 0.642 0.0968 7.98 <0.01 Significant 
2 Tender spots 3.4545 2.4545 1 0.482 0.0727 13.76 <0.01 Significant 
3 Presence of nodules 3 2.2272 0.7727 0.604 0.091 8.49 <0.01 Significant 
4 Local twitch points 2.0681 1.3181 0.75 0.575 0.0867 8.65 <0.01 Significant 
5 Referred pain 1.8636 0.5454 0.5454 0.503 0.0758 7.195 <0.01 Significant 
Table 2: Comparative assessment of symptomatic relief in intervention group 
S.NO Symptoms Mean 
BT 
Mean 
AT 
Mean 
diff 
SD SE T 
value 
P 
value 
result 
1 Presence of taut band 2.1428 0.1904 1.9523 0.6228 0.0961 20.315 <0.01 H. significant 
2 Tender spots 3.4047 0.238 3.1667 0.8239 0.1271 24.91 <0.01 H. significant 
3 Presence of nodules 3.0476 0.333 2.7142 0.8050 0.1242 21.85 <0.01 H. significant 
4 Local twitch points 2.1428 0.1904 1.9523 0.6608 0.1019 19.16 <0.01 H. significant 
5 Referred pain 1.8095 0.1667 1.6428 0.6176 0.0953 17.24 <0.01 H. significant 
Table 3: Comparative assessment of control group and intervention group 
S.NO Symptoms Mean 
control 
Mean 
intervention 
Mean 
diff 
SE T 
value 
P value result 
1 Presence of taut band 1.5227 0.1904 1.3323 0.1277 10.429 < 0.01 Significant 
2 Tender spots 2.4545 0.238 2.2165 0.1383 16.626 < 0.01 Significant 
3 Presence of nodules 2.2272 0.333 1.8942 0.1394 13.589 < 0.01 Significant 
4 Local twitch points 1.3181 0.1904 1.1277 0.1289 8.744 < 0.01 Significant 
5 Referred pain 1.3181 0.1667 1.1514 0.1186 9.711 < 0.01 Significant 
Primary outcome measure 
I. OLBPD questionnaire –(Subjective parameters) 
 The difference between the intervention group and the control group was significant after 6 weeks. The difference 
of the mean value before treatment and after six weeks for the control group and intervention group are 14.13 and 33.09 
respectively. The multivariate test for repeated measures shows there is significant difference in OLBPD scores at 1% level 
of significance. There is a significant difference between level 1 and level 2.But level 2 and level 3 do not show a significant 
difference. 
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Table 4: Showing effect of therapy in low back pain disability score 
Descriptive Statistics 
 Group Mean Std. Deviation N 
OLBP1 Control 62.33 10.67 44 
Intervention 48.46 12.92 42 
Total 55.56 13.67 86 
OLBP2 Control 53.09 9.58 44 
Intervention 10.14 7.09 42 
Total 32.11 23.18 86 
OLBP3 Control 48.20 9.10 44 
Intervention 14.37 32.83 42 
Total 31.68 29.17 86 
 
Fig.1: Showing effect of therapy in low back pain disability score 
Table 5: The following test shows there is significant difference in OLBP scores among 3 levels in between control and 
intervention at 1% level of significance. 
Measure: OLBP 
Transformed Variable: Average 
Source Type III Sum of Squares df Mean Square F Sig. 
Intercept 133640.912 1 133640.912 1147.84 .000 
group 19619.026 1 19619.026 168.508 .000 
Error 9779.964 84 116.428   
CONTROL 
Table 6: Multivariate Tests 
Effect Value F Hypothesis df Error df Sig. 
Time Pillai's Trace 0.837 107.85 2.000 42.000 .000 
Wilks' Lambda 0.163 107.85 2.000 42.000 .000 
Hotelling's Trace 5.136 107.85 2.000 42.000 .000 
Roy's Largest Root 5.136 107.85 2.000 42.000 .000 
Table 7: Tests of Within-Subjects Contrasts a 
Measure: OLBP 
Source Time Type III Sum of Squares df Mean Square F Sig. 
Time Level 1 vs. Level 2 3754.582 1 3754.582 151.432 .000 
 Level 2 vs. Level 3 1053.502 1 1053.502 38.753 .000 
 The multivariate test for repeated measures shows there is significant difference in OLBP scores in between 3 repeated 
measures at 1% level of significance (F=107.85, P-value <.01) 
The above test shows there is significant difference in between first and second sets at 1% level of significance. Also, there 
is significant difference in between second and third sets at 1% level of significance. 
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Intervention 
Table 8: Multivariate Tests 
Effect Value F Hypothesis df Error df Sig. 
Time Pillai's Trace 0.898 176.18 2.000 40.000 .000 
Wilks' Lambda 0.102 176.18 2.000 40.000 .000 
Hotelling's Trace 8.809 176.18 2.000 40.000 .000 
Roy's Largest Root 8.809 176.18 2.000 40.000 .000 
The multivariate test for repeated measures shows there is significant difference in OLBP scores in between 3 repeated 
measures at 1% level of significance (F=176.18, P-value <.01). 
Table 9: Tests of Within-Subjects Contrasts a 
Measure: OLBP 
Source Time Type III Sum of Squares df Mean Square F Sig. 
Time Level1 vs. Level2 61678.339 1 61678.339 359.831 .000 
 Level 2 vs. Level 3 752.687 1 752.687 .656 .423 
a. group = Intervention 
The above test shows there is significant difference in between first and second sets at 1% level of significance. But, there 
is no significant difference in between second and third sets.  
Secondary outcomes –(Subjective parameters) 
II. VASP- showing effect of therapy in pain index 
Table 10: 1VASP- showing effect of therapy in pain index 
Descriptive Statistics 
 Group Mean Std. Deviation N 
VASP1 Control 6.68 0.674 44 
Intervention 6.21 0.871 42 
Total 6.45 0.807 86 
VASP2 Control 5.23 0.677 44 
Intervention 2.45 0.633 42 
Total 3.87 1.540 86 
VASP3 Control 4.91 0.640 44 
Intervention 2.05 0.731 42 
Total 3.51 1.592 86 
VAS-P1, VAS-P2 and VAS-P3 
 The intervention group showed, on average, significantly lower scores on all VAS-P scales compared with the 
control group after 6 weeks: The difference of the mean value at the baseline and after six weeks for the control group was 
1.97 and that for intervention group was 4.16. The graphical representation of estimated marginal means of VASP is 
shown in Fig.2. For the control group, the test shows, there is a significant difference in between first and second levels at 
1% level of significance. Also there is significant difference between second and third level. For the intervention group, the 
P- value <0.01 shows that there is significant difference between each levels. 
 
Fig.2 VASP-showing effect of therapy in pain index 
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Table 11: The following test shows there is significant difference in VASP scores among 3 levels in between control and 
intervention at 1% level of significance 
Measure: VASP 
Transformed Variable: Average 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Intercept 1809.886 1 1809.886 5363.3 .000 
Group 88.956 1 88.956 263.608 .000 
Error 28.346 84 .337   
1. Control 
Table 12: Multivariate Tests b 
Effect Value F Hypothesis df Error df Sig. 
Time Pillai's Trace .855 124.30 2.000 42.000 .000 
Wilks' Lambda .145 124.30 2.000 42.000 .000 
Hotelling's Trace 5.919 124.30 2.000 42.000 .000 
Roy's Largest Root 5.919 124.30 2.000 42.000 .000 
The multivariate test for repeated measures shows there is significant difference in VASP scores in between 3 repeated 
measures at 1% level of significance (F=124.30, P-value <.01). 
Table 13: Tests of Within-Subjects Contrasts a 
Measure: VASP 
 Source Time Type III Sum of Squares df Mean Square F Sig. 
Time Level 1 vs. Level 2 93.091 1 93.091 174.730 0.000 
Level 2 vs. Level 3 4.455 1 4.455 16.591 0.000 
a group = Control 
The above test shows there is significant difference in between first and second sets at 1% level of significance. Also, there 
is significant difference in between second and third sets at 1% level of significance. 
2. Intervention 
Table 14: Multivariate Tests b 
Effect Value F Hypothesis df Error df Sig. 
Time Pillai's Trace 0.970 639.785 2.000 40.000 .000 
Wilks' Lambda 0.030 639.785 2.000 40.000 .000 
Hotelling's Trace 31.989 639.785 2.000 40.000 .000 
Roy's Largest Root 31.989 639.785 2.000 40.000 .000 
b. group = Intervention 
The multivariate test for repeated measures shows there is significant difference in VASP scores in between 3 repeated 
measures at 1% level of significance (F=639.785, P-value <.01). 
Table 15: Tests of Within-Subjects Contrasts a 
Measure: VASP 
 Source time Type III Sum of Squares df Mean Square F Sig. 
Time Level 1 vs. Level 2 594.381 1 594.381 1031.77 .000 
Level 2 vs. Level 3 6.881 1 6.881 17.502 .000 
a. group = Intervention 
The above test shows there is significant difference in between first and second sets at 1% level of significance. Also, there 
is significant difference in between second and third sets at 1% level of significance. 
Table 16: Assessment of OLBP and VASP for control group 
SNO symptoms Mean Bt Mean AT Mean diff SD SE P value result 
1 OLBP 62.328 48.197 14.1306 6.6 0.9949 <0.01 significant 
2 VASP 6.6818 4.909 1.7727 0.742 0.1118 <0.01 significant 
Table 17: Assessment of OLBP and VASP for intervention group 
SNO Symptoms Mean Bt Mean AT Mean diff SD SE P value Result 
1 OLBP 48.4595 9.1875 39.273 12.342 1.904 <0.01 H.Significant 
2 VASP 6.2142 2.0476 2.0476 0.7937 0.122 <0.01 H.Significant 
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III. Number of trigger points (Objective parameters) 
 The number of active MTrPs was significantly lower in the intervention group than in the control group after 6 
weeks. The control group’s mean value varies from 6.05 (at the base line) to 4.59 (after six weeks). The mean of 
intervention group varies from 5.71 to 1.95. The graphical presentation of the mean of TrP is given by Fig.3. The 
multivariate test for repeated measures shows there is significant difference in TrP scores in between 3 repeated 
measures at 1% level of significance for the control group as well as the intervention group. 
When we tested the significance within each level, the control group showed in between first and second levels at 1% level 
of significance. But there is no significant difference between level 2 and 3 at 1% level of significance. (P value >01)  
For the intervention group, there is significant difference between level 1 and level 2, and also between level 2 and level 3 
at 1% level of significance. 
Table 18: Shows the effect of therapy in the number of trigger points in lower back muscles 
Descriptive Statistics 
 Group Mean Std. Deviation N 
TrP1 Control 6.05 1.275 44 
Intervention 5.71 1.066 42 
Total 5.88 1.182 86 
TrP2 Control 4.86 0.979 44 
Intervention 2.48 0.671 42 
Total 3.70 1.464 86 
TrP3 Control 4.59 0.996 44 
Intervention 1.95 0.731 42 
Total 3.30 1.587 86 
 
Fig 3: The effect of therapy in the number of trigger points in lower back muscles 
Table 19: The following test shows there is significant difference in TrP scores among 3 levels in between control and 
intervention at 1% level of significance. 
Measure: TrP 
Transformed Variable: Average 
Source Type III Sum of Squares df Mean Square F Sig. 
Intercept 1569.979 1 1569.979 2173.2 .000 
group 68.522 1 68.522 94.851 .000 
Error 60.683 84 .722   
1. CONTROL 
Table 20: Multivariate Tests b 
Effect Value F Hypothesis df Error df Sig. 
Time Pillai's Trace 0.812 90.747 2.000 42.000 .000 
Wilks' Lambda 0.188 90.747 2.000 42.000 .000 
Hotelling's Trace 4.321 90.747 2.000 42.000 .000 
Roy's Largest Root 4.321 90.747 2.000 42.000 .000 
b. group = Control 
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The multivariate test for repeated measures shows there is significant difference in TrP scores in between 3 repeated 
measures at 1% level of significance (F=90.747, P-value <.01). 
Table 21: Tests of Within-Subjects Contrasts a 
Measure: TrP 
 Source Time Type III Sum of Squares df Mean Square F Sig. 
Time Level 1 vs. Level 2 61.455 1 61.455 159.714 .000 
Level 2 vs. Level 3 3.273 1 3.273 5.691 .022 
The above test shows there is significant difference in between first and second sets at 1% level of significance. Also, there 
is significant difference in between second and third sets at 5% level of significance. 
2. INTERVENTION 
Table 22: Multivariate Tests b 
Effect Value F Hypothesis df Error df Sig. 
Time Pillai's Trace .933 278.200 2.000 40.000 .000 
Wilks' Lambda .067 278.200 2.000 40.000 .000 
Hotelling's Trace 13.910 278.200 2.000 40.000 .000 
Roy's Largest Root 13.910 278.200 2.000 40.000 .000 
The multivariate test for repeated measures shows there is significant difference in TrP scores in between 3 repeated 
measures at 1% level of significance (F=278.2, P-value <.01). 
Table 23: Tests of Within-Subjects Contrasts a 
Measure: TrP 
Source time Type III Sum of Squares df Mean Square F Sig. 
Time Level 1 vs. Level 2 440.381 1 440.381 506.909 .000 
Level 2 vs. Level 3 11.524 1 11.524 25.572 .000 
a. group = Intervention 
 The above test shows there is significant 
difference in between first and second sets at 1% level of 
significance. Also, there is significant difference in between 
second and third sets at 1% level of significance. 
DISCUSSION 
Summary of main findings 
 This single-blinded RCT evaluated the 
effectiveness of a 6-week comprehensive neuro muscular 
therapy (NMT) program in patients with chronic, non 
traumatic, low back pain when compared with a control 
group. After 6 weeks, the intervention group showed 
statistically as well as clinically significant differences 
compared with the control group on the primary and 
secondary outcome measures. The NMT consists of 
ischemic compression by means of applying direct 
sustained digital pressure to the TrP with sufficient force 
over 10 to 16 seconds, The pressure is gradually applied, 
maintained and gradually released. The area is then 
massaged, stretched manually and apply Dhanyamla dhara 
as to reduce the tension in the affected muscle and 
subsequently reduce the pain. The combination of NMT 
and Dhanyamla dhara showed more effective in the 
targeted approach to releasing the TrPs. While the control 
group was received only Dhanyamla dhara. The sudation 
procedures like Dhanyamla dhara, Pathrapotala sweda etc. 
are commonly utilized for achieving pain reduction in 
musculo skeletal disorders. That is why both groups 
demonstrated significant levels of improvement in pain 
intensity (p<0.01) and low back pain disability index 
(p<0.01). The between-group analysis indicated that there 
was significantly greater improvement in pain and OLBPD 
favoring the group receiving the NMT with Dhanyamla 
dhara. The effect sizes were considered to be medium and 
consistent with the hypothesized effect size. The number 
of back and buttock muscles with active MTrPs was 
significantly lower in the intervention group than in the 
control group, supporting the assumed biomedical 
mechanism underlying MTrP therapy. In the present study, 
the NMT with sudation procedures (Dhanyamla dhara) 
was found superior versus Dhanyamla dhara only in its 
ability to improve pain, low back pain disability index, 
number of trigger points and the symptomatic parameters. 
 In the present study most of the participants were 
diagnosed previously as IVDP and were treated with 
NSAIDs. On keen observation and history taking, it was 
revealed that there was strong evidence of the presence of 
Trps in the back and buttock muscles. Hence we can 
assume that the MTrPs are the main causative factor for 
IVDP. 
CONCLUSION 
 Participants in the intervention group had better 
outcomes on all outcome measures after 6 weeks of a 
comprehensive MTrP treatment program than did those 
on the control group. Clinically relevant improvements 
were achieved in 85% of the patients with low back pain, 
and the number of muscles with active MTrPs was 
significantly decreased. 
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